Expression and role of p27(kip1) in neuronal differentiation of embryonal carcinoma cells

Molecular Brain Research

Volumn 77, Issue 2, 2000, Pages 209-221

  Sasaki, Kobo ^a   Tamura, Shu ^a   Tachibana, Hisao ^a   Sugita, Minoru ^a   Gao, Ying ^a   Furuyama, Jun ichi ^a   Kakishita, Eizo ^a   Sakai, Toshiyuki ^b   Tamaoki, Taiki ^c   Hashimoto Tamaoki, Tomoko ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antisense oligonucleotides; Neuronal differentiation; P19 embryonal carcinoma cell; p21(waf1); p27(kip1); Retinoic acid

Indexed keywords

PROTEIN P27;

ANIMAL CELL; ARTICLE; EMBRYONAL CARCINOMA; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DIMETHYL SULFOXIDE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEURITES; NEUROFILAMENT PROTEINS; NEURONS; OKADAIC ACID; OLIGONUCLEOTIDES, ANTISENSE; PROMOTER REGIONS (GENETICS); RECEPTOR, TRKB; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRETINOIN; TUMOR CELLS, CULTURED; TUMOR STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; ATRA;

EID: 0034608062     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00053-X     Document Type: Article

References (72)

1. kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16:1996;4327-4336.
2. Bain G., Ray W.J., Yao M., Gottlieb D.I. From embryonal carcinoma cells to neurons: the P19 pathway. Bioessays. 16:1994;343-348.
3. Boulikas T. Phosphorylation of transcription factors and control of the cell cycle. Crit. Rev. Eukaryot. Gene Expr. 5:1995;1-77.
4. Kip1. Genes Dev. 11:1997;2335-2346.
5. Clark A.R., Maandag E.R., van Roon M., van der Lugt N.M., van der Valk M., Hooper M.L., Berns A., te Riele H. Requirement for a functional Rb-1 gene in murine development. Nature. 359:1992;328-330.
6. Kip1 for restriction point control of the fibroblast cell cycle. Science. 272:1996;877-880.
7. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
8. Dulic V., Kaufmann W.K., Wilson S.J., Tlsty T.D., Lees E., Harper J.W., Elledge S.J., Reed S.I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.
9. Durand B., Gao F.B., Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16:1997;306-317.
10. Duronio R.J., O'Farrell P.H. Developmental control of a G1-S transcriptional program in Drosophila. Development. 120:1994;1503-1515.
11. El-Deiry W.S., Tokino T., Velculescu E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
12. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., Kaushansky K., Roberts J.M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1) deficient mice. Cell. 85:1996;733-744.
13. Frisen J., Verge V.M., Freid K., Risling M., Persson H., Trotter J., Hokfelt T., Lindholm D. Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems. Proc. Natl. Acad. Sci. USA. 90:1993;4971-4975.
14. Gu Y., Turck C.W., Morgan D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 366:1993;707-710.
15. Guo K., Wang J., Andres V., Smith R.C., Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:1995;3823-3829.
16. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee J., Hannon G.J., Beach D., Lassar A. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1995;1018-1021.
17. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
18. Kip1 accumulation during the cell cycle. Science. 271:1996;1861-1864.
19. Hofbauer R., Denhardt D.T. Cell cycle-regulated and proliferation stimulus-responsive genes. Crit. Rev. Eukaryot. Gene Expr. 1:1991;247-300.
20. Hogan B.L., Taylor A., Adamson E. Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm. Nature. 291:1981;235-237.
21. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature. 359:1992;295-300.
22. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
23. Jones-Villeneuve E.M., McBurney M.W., Rogers K.A., Kalnins V.I. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell Biol. 94:1982;253-262.
24. Jones-Villeneuve E.M., Rudnicki M.A., Harris J.F., McBurney M.W. Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 3:1983;2271-2279.
25. Kamb A., Shattuck-Eidens D., Eeles R., Liu Q., Gruis N.A., Ding W., Hussey C., Tran T., Miki Y., Weaver-Feldhaus J., McClure M., Aitken J.F., Anderson D.E., Bergman W., Frants R., Goldgar D.E., Green A., MacLennan R., Martin N.G., Meyer L.J., Youl P., Zone J.J., Skolnick M.H., Cannon-Albright L.A. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8:1994;23-26.
26. Kaplan D.R., Matsumoto K., Lucarelli E., Thiele C.J. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron. 11:1993;321-331.
27. Kato A., Takahashi H., Takahashi Y., Matsushime H. Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition. J. Biol. Chem. 272:1997;8065-8070.
28. Kawasaki H., Eckner R., Yao T.P., Taira K., Chiu R., Livingston D.M., Yokoyama K.K. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature. 393:1998;284-289.
29. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., Khanam D., Hayday A.C., Frohman L.A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85:1996;721-732.
30. Klein R., Parada L.F., Coulier F., Barbacid M. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J. 8:1989;3701-3709.
31. Kranenburg O., Scharnhorst V., Van der Eb A.J., Zantema A. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J. Cell Biol. 131:1995;227-234.
32. Kranenburg O., de Groot R.P., Van der Eb A.J., Zantema A. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene. 10:1995;87-95.
33. Lassar A.B., Skapek S.X., Novitch B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:1994;788-794.
34. Lee E.Y., Chang C.Y., Hu N., Wang Y.C., Lai C.C., Herrup K., Lee W.H., Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 359:1992;288-294.
35. Liu M., Iavarone A., Freedman L.P. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271:1996;31723-31728.
36. Kip1, is required for IL-4 regulation of astrocyte proliferation. J. Immunol. 159:1997;812-818.
37. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:1995;650-662.
38. McBurney M.W. P19 embryonal carcinoma cells. Int. J. Dev. Biol. 37:1993;135-140.
39. McBurney M.W., Rogers B.J. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Dev. Biol. 89:1982;503-508.
40. McBurney M.W., Jones-Villeneuve E.M., Edwards M.K., Anderson P.J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature. 299:1982;165-167.
41. Kip1 gene promoter. FEBS Lett. 411:1997;1-6.
42. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y., Nakayama K. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720.
43. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368:1994;753-756.
44. Kip1 in anchorage-independent cells. Oncogene. 16:1998;2575-2583.
45. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685.
46. Park M.S., Rosai J., Nguyen H.T., Capodieci P., Cordon-Cardo C., Koff A. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc. Natl. Acad. Sci. USA. 96:1999;6382-6387.
47. Cip1 in muscle and other terminally differentiating cells. Science. 267:1995;1024-1027.
48. Perez-Juste G., Aranda A. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. J. Biol. Chem. 274:1999;5026-5031.
49. Poluha W., Poluha D.K., Chang B., Crosbie N.E., Schonhoff C.M., Kilpatrick D.L., Ross A.H. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16:1996;1335-1341.
50. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59-66.
51. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
52. Pratt M.A., Kralova J., McBurney M.W. A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol. Cell. Biol. 10:1990;6445-6453.
53. Reynisdottir I., Massague J. The subcellular locations of p15 (Ink4b) and p27 (Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Gene Dev. 15:1997;492-503.
54. Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 271:1996;18337-18341.
55. Rudnicki M.A., McBurney M.W. Cell culture methods and induction of differentiation of embryonal carcinoma cell lines. Robertson E.J. Teratocarcinomas and embryonic stem cells. 1987;19-49 IRL Press, Oxford.
56. Salvatore A.M., Cozzolino M., Gargano N., Galanti S., Levi A., Alema S. Neuronal differentiation of P19 embryonal cells exhibits cell-specific regulation of neurotrophin receptors. Neuroreport. 6:1995;873-877.
57. Sasahara Y., Kobayashi T., Onodera H., Onoda M., Ohnishi M., Kato S., Kusuda K., Shima H., Nagao M., Abe H., Yanagawa Y., Hiraga A., Tamura S. Okadaic acid suppresses neural differentiation-dependent expression of the neurofilament-L gene in P19 embryonal carcinoma cells by post-transcriptional modification. J. Biol. Chem. 271:1996;25950-25957.
58. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Cell. 85:1996;27-37.
59. Kip1. Genes Dev. 11:1997;1464-1478.
60. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
61. Singh S.P., Lipman J., Goldman H., Ellis F.H. Jr., Aizenman L., Cangi M.G., Signoretti S., Chiaur D.S., Pagano M., Loda M. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 15:1998;1730-1735.
62. Slack R.S., Hamel P.A., Bladon T.S., Gill R.M., McBurney M.W. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene. 8:1993;1585-1591.
63. Slingerland J.M., Hengst L., Pan C.H., Alexander D., Stampfer M.R., Reed S.I. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol. 14:1994;3683-3694.
64. Sowa Y., Orita T., Minamikawa S., Nakano K., Mizuno T., Nomura H., Sakai T. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241:1997;142-150.
65. Kip1 on resistance of tumor cells to anticancer agents. Nat. Med. 2:1996;1204-1210.
66. Tang X.M., Beesley J.S., Grinspan J.B., Seth P., Kamholz J., Cambi F. Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. J. Cell. Biochem. 76:1999;270-279.
67. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:1994;67-74.
68. Williams B.O., Schmitt E.M., Remington L., Bronson R.T., Albert D.M., Weinberg R.A., Jacks T. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13:1994;4251-4259.
69. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
70. Yamamoto H., Fujimoto J., Okamoto E., Furuyama J., Tamaoki T., Hashimoto-Tamaoki T. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. Int. J. Cancer. 76:1998;897-902.
71. Yokota Y., Ohkubo H. 9-cis-retinoic acid induces neuronal differentiation of retinoic acid-nonresponsive nonresponsive embryonal carcinoma cells. Exp. Cell Res. 228:1996;1-7.
72. WAF1/CIP1 expression by p53-independent pathways. Oncogene. 12:1996;1557-1564.